19/12/2014 17:44:24 Free Membership Login

   

Alexion Pharmaceuticals, Inc.

Visual Financials
Company Name: Alexion Pharmaceuticals, Inc.
Ticker Symbol: ALXN
WWW Address: http://www.alexionpharm.com
CEO: Leonard Bell
No. of Employees: 1,373
Common Issue Type: CS
Business Description:Alexion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 189.51 Up 0.55 189.48 189.62 190.53 191.61 187.64 2050885
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 37,577.3 198.3 0.00 1.29 0.00 148.5 0.0 203.30 - 126.76
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close189.53$
PE Ratio - LTM148.5
Market Capitalisation37,577.3mil
Latest Shares Outstanding198.3mil
Earnings pS (EPS)1.29$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float153.6mil
Float as % of Shares Outstanding0.8%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin88.6%
EBITDA Margin36.0%
Pre-Tax Profit Margin33.9%
Assets Turnover52.3%
Return on Assets (ROA)8.5%
Return on Equity (ROE)11.6%
Return on Capital Invested (ROCI)11.0%
Current Ratio3.8
Leverage Ratio (Assets/Equity)1.4
Interest Cover129.0
Total Debt/Equity (Gearing Ratio)0.06
LT Debt/Total Capital4.0%
Working Capital pS8.09$
Cash pS0.00$
Book-Value pS15.75$
Tangible Book-Value pS7.66$
Cash Flow pS2.80$
Free Cash Flow pS2.34$
KEY FIGURES (LTM): Price info
Price/Book Ratio11.86
Price/Tangible Book Ratio0.00
Price/Cash Flow66.7
Price/Free Cash Flow80.0
P/E as % of Industry Group241.0%
P/E as % of Sector Segment48.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---203.30175.92421
4 Weeks191.61187.64187.64203.30175.9218417
13 Weeks189.53189.532048809176.01203.3018917
26 Weeks2048809203.30203.30191.96203.30189-2
52 Weeks176.01176.01191.02203.30126.08187-2
YTD126.76126.76-203.30126.76245
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
155.01155.01161.44161.44203.300.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue229346901480413514804135
Income229346902293469073949673
Dividend73949673145273486145273486
Capital Spending335734543NA335734543
R&D19099224NA19099224
Normalized Inc.73949673NA73949673
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %13-4-4
Earnings %303029
EPS %909393
EPS $297575
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio3317696000
Quick Ratio (Acid Test)1130839000
Liquidity Ratio (Cash)0.00
Receivables Turnover53801000
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS2382079000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)21596000
Debt Ratio935617000
Total Debt/Equity (Gearing Ratio)Av
LT Debt/Equity154717000
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities935617000
Interest Cover-104105000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM146,241,234.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow8.11
Dividend Yield8599205
Price/Tangible Book Ratio - LTM49
Price/Book Ratio - LTM1333034
Price/Cash Flow Ratio3.8
Price/Free Cash Flow Ratio - LTM49
Price/Sales Ratio-3.00
P/E Ratio (1 month ago) - LTM146241234
P/E Ratio (26 weeks ago) - LTM247221244
P/E Ratio (52 weeks ago) - LTM247221244
5-Y High P/E Ratio337257652
5-Y Low P/E Ratio330031890
5-Y Average P/E Ratio1417621
Current P/E Ratio as % of 5-Y Average P/E1417621
P/E as % of Industry Group1,146,734.0
P/E as % of Sector Segment1,146,734.0
Current 12 Month Normalized P/E Ratio - LTM1,345,830.0
PER SHARE FIGURES
LT Debt pS32230000
Current Liabilities pS
Tangible Book Value pS - LTM3.8
Book Value pS - LTM1333034
Capital Invested pS0.00
Cash pS - LTM398138
Cash Flow pS - LTM2.21
Free Cash Flow pS - LTM2.21
Earnings pS (EPS)1151
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-104105000
Net Profit Margin - 5YEAR AVRG.2014-10-22
Equity Productivity0.00
Return on Equity (ROE)2382079000
Return on Equity (ROE) - 5YEAR AVRG.37059817685
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-96
Assets Productivity21,596,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.37059817685
Gross Profit Margin1146734
Gross Profit Margin - 5YEAR AVRG.-96
EBITDA Margin - LTM1137687
EBIT Margin - LTM1146734
Pre-Tax Profit Margin201109000
Pre-Tax Profit Margin - 5YEAR AVRG.198286879
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle582,428,721
Revenue per Employee
Net Income per Employee609,719,000
Average Collection Period
Receivables Turnover53801000
Day's Inventory Turnover Ratio582429000
Inventory Turnover53801000
Inventory/Sales32230000
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover21596000
Revenue per $ Cash105895000
Revenue per $ Plant105895000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.198286879
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq alxn141219 17:44